PIM1 and acute lymphoblastic leukemia: High PIM1 expression is a biomarker in T-ALL cases with JAK/STAT activation and response of leukemic cells to endogenous IL7 [39, 40], with PIM targeting cooperating with chemotherapy to promote leukemic mice survival in T-ALL PDXs [40].